Hong Kong Exchanges and Clearing Limited (HKEX) today welcomed the Government’s appointment of Nisa Leung and the reappointment of Rafael Gil-Tienda and Stephen Yiu to its Board of Directors.

The two-year terms of the three directors will begin at the conclusion of HKEX’s Annual General Meeting (AGM) in 2021, and will end at the conclusion of the AGM in 2023.

Anita Fung will retire from the Board after the conclusion of the AGM on 28 April 2021.

“We warmly welcome the appointment of Ms Nisa Leung to our Board of Directors. Her extensive expertise in venture capital, innovation, biotech and healthcare, and her deep knowledge of the Mainland China investment market, will be immensely valuable to the Board and to HKEX’s future development,” said HKEX Chairman Laura M Cha.

Ms Leung has been managing partner at Qiming Venture Partners since 2013. She is also non-executive director of Zai Lab Limited, Venus Medtech (Hangzhou) Inc, and CanSino Biologics Inc. She has also been a non-executive director of Gan & Lee Pharmaceutical Holdings Ltd since 2009.

Nisa Leung has a Bachelor of Science degree from the Cornell University (United States) and an MBA from Stanford University (United States).